Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Dopamine“
Suchtreffer
Begriffe & Kennungen
Neoatricon · 4.8 · Increase in hypoxemia Dopamine may contribute to hypoxemia by several mechanisms, e.g. by ventilation-perfusio
Eintrag öffnenNeoatricon · 4.8 · Suppression of pituitary function Due to activation of D2 receptors in the pituitary gland, dopamine suppresse
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Because rotigotine is a dopamine agonist, it is assumed that dopamine antagonists, such as neuroleptics (e.g.
Eintrag öffnenNeupro · 4.5 · Neupro may potentiate the dopaminergic adverse reaction of L-dopa and may cause and/or exacerbate pre-existing
Eintrag öffnenNeupro · 4.5 · Neupro may potentiate the dopaminergic adverse reaction of L-dopa and may cause and/or exacerbate pre-existing
Eintrag öffnenNeupro · 4.5 · Neupro may potentiate the dopaminergic adverse reaction of L-dopa and may cause and/or exacerbate pre-existing
Eintrag öffnenNeupro · 4.8 · At the beginning of therapy dopaminergic adverse reactions such as nausea and vomiting may occur. These are us
Eintrag öffnenNeupro · 4.8 · At the beginning of therapy dopaminergic adverse reactions such as nausea and vomiting may occur. These are us
Eintrag öffnenNeupro · 4.8 · At the beginning of therapy dopaminergic adverse reactions such as nausea and vomiting may occur. These are us
Eintrag öffnenNeupro · 4.8 · At the beginning of therapy dopaminergic adverse reactions such as nausea and vomiting may occur. These are us
Eintrag öffnenOkedi · 4.5 · Levodopa and dopamine agonists OKEDI may antagonise the effect of levodopa and other dopamine agonists. If thi
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 25 In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s d
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · 40 In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s d
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnenOlanzapine Glenmark Europe · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnenOlanzapine Glenmark · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnenOlanzapine Glenmark · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnen